Advancing fertility-sparing treatments in cervical cancer: where is the limit?
Gynecol Oncol
.
2012 Sep;126(3):317-8.
doi: 10.1016/j.ygyno.2012.07.093.
Authors
Lua Eiriksson
,
Allan Covens
PMID:
22840441
DOI:
10.1016/j.ygyno.2012.07.093
No abstract available
Publication types
Editorial
MeSH terms
Chemotherapy, Adjuvant
Female
Fertility Preservation*
Humans
Lymphatic Metastasis
Neoadjuvant Therapy
Uterine Cervical Neoplasms / pathology*
Uterine Cervical Neoplasms / therapy*